Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06220266

Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Dhurakij Pundit University · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to learn about the effects of phytoestrogen from Pueraria Mirifica in improvement of serum lipid parameters. The primary question it aims to answer are: • phytoestrogen from Pueraria Mirifica can reduce serum triglyceride, total cholesterol, LDL and increase HDL or not Participants will receive capsules which composed of dry weight 50 mg of Pueraria Mirifica twice a day for 2 months. Researchers will compare with diet control\&life style modification to see if there is the improvement of serum lipid parameters

Detailed description

The secondary question it aims to answer are: * phytoestrogen from Pueraria Mirifica can reduce menopausal symptom score or not * phytoestrogen from Pueraria Mirifica can reduce body mass index(BMI) or not * phytoestrogen from Pueraria Mirifica can reduce waist circumference or not * phytoestrogen from Pueraria Mirifica can reduce blood pressure or not * phytoestrogen from Pueraria Mirifica effects to creatinine, BUN, eGFR or not * phytoestrogen from Pueraria Mirifica effects liver function enzymes or not

Conditions

Interventions

TypeNameDescription
DRUGPhytoestrogenconsume 1 capsule twice a day for 2 months which one capsule composed of dry weight 50 mg of Pueraria Mirifica 1or Pueraria Mirifica 2 or Pueraria Mirifica 3
DRUGDiet control & life style modificationDiet control \& life style modification

Timeline

Start date
2024-03-02
Primary completion
2024-08-01
Completion
2024-11-01
First posted
2024-01-23
Last updated
2024-05-24

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT06220266. Inclusion in this directory is not an endorsement.